高级检索
当前位置: 首页 > 详情页

MicroRNA-222-3p participates in the development of oral squamous cell carcinoma by targeting CDKN1B

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Stomatology, The Fourth Hospital of HeBei Medical University, Shijiazhuang, China [2]Department of Stomatology, People's Hospital of Lingshou County, Shijiazhuang, China [3]Department of Stomatology, Third Hospital of Hebei Medical University, Shijiazhuang, China [4]Department of Stomatology, Handan First Hospital, Handan, China
出处:
ISSN:

关键词: CDKN1B microRNA-222-3p oral squamous cell carcinoma prognosis progression

摘要:
Objective The aim of this study was to explore the potential role and regulatory mechanism of microRNA (miR)-222-3p in oral squamous cell carcinoma (OSCC). Methods The expression level and prognostic significance of miR-222-3p was detected in OSCC tissues. CCK-8, transwell, and flow cytometry assays were used to explore the effect of miR-222-3p on cell proliferation, migration, invasion, and apoptosis. The influence of miR-222-3p on cyclin-dependent kinase inhibitor 1B (CDKN1B) expression was evaluated by luciferase assays, real-time polymerase chain reaction, and Western blot. Results We found that miR-222-3p was overexpressed in OSCC tissues, comparing with normal tissues. Kaplan-Meier curves showed that OSCC patients with high expression of miR-222-3p (P = .003) showed worse overall survival than those patients with low expression of miR-222-3p. Multivariate analysis showed that miR-222-3p (P = .037) expression was an independent prognostic factor of OSCC patients. miR-222-3p promoted cell proliferation, migration and invasion and induced the apoptosis of SCC-15 and Tca-83 cells. Furthermore, luciferase reporter assays indicated that CDKN1B is targeted by miR-222-3p in OSCC cells. Overexpression of CDKN1B inhibited OSCC cell proliferation, migration, and invasion and promoted cell apoptosis rate. Conclusions miR-222-3p affects OSCC cell proliferation, migration, invasion, and apoptosis through targeting CDKN1B, and may be a potential prognostic biomarker for OSCC patients.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 2 区 牙科与口腔外科 3 区 病理学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 牙科与口腔外科 3 区 病理学
JCR分区:
出版当年[2020]版:
Q1 DENTISTRY, ORAL SURGERY & MEDICINE Q2 PATHOLOGY
最新[2023]版:
Q1 DENTISTRY, ORAL SURGERY & MEDICINE Q2 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Stomatology, The Fourth Hospital of HeBei Medical University, Shijiazhuang, China
通讯作者:
通讯机构: [1]Department of Stomatology, The Fourth Hospital of HeBei Medical University, Shijiazhuang, China [*1]Department of Stomatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号